Angiotensin receptor blockade blunts hyperinsulinemia-induced hypertension in rats

Hypertension

Volumn 32, Issue 2, 1998, Pages 235-242

  Fang, Te Chao ^a,b   Huang, Wann Chu ^b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Angiotensin receptor antagonist; Hyperinsulinemia; Insulin resistance; Losartan; PD123319

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; INSULIN; LOSARTAN; RECEPTOR SUBTYPE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0031845973     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.2.235     Document Type: Article

References (46)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988; 37:1595-1607.
2. Modan M, Halkin H, Almog S, Lusky A, Eshkol M, Shitrit A, Fuchs Z. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest. 1985;75:809-817.
3. Ferrannini E, Buzzigoli G, Bonadonna R. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
4. Mondan CE, Reaven GM. Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension. Metabolism. 1988;37: 303-305.
5. Bursztyn M, Ben-Ishay D, Gutman A. Insulin resistance in spontaneously hypertensive rats but not deoxycorticosterone-salt or renal vascular hypertension. J Hypertens. 1992;10:137-142.
6. Dall'Aglio E, Tosini P, Ferrari P, Zavaroni I, Passen M, Reaven GM. Abnormalities of insulin and lipid metabolism in Milan hypertensive rats. Am J Hypertens. 1991;4:773-775.
7. Kotchen TA, Zhang HY, Covelli M, Blehshmidt N. Insulin resistance and blood pressure in Dahl rats and in one-kidney, one clip hypertensive rats. Am J Physiol. 1991;261:E692-E697.
8. Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose induced insulin resistance and hypertension in rats. Hypertension. 1987;10:512-516.
9. Hwang IS, Huang WC, Wu JN, Shian LR, Reaven GM. Effect of fructose-induced hypertension on the renin-angiotensin-aldosterone system and atrial natriuretic factor. Am J Hypertens. 1989;2:424-427.
10. Reaven GM, Ho H. Sugar-induced hypertension in Sprague-Dawley rats. Am J Hypertens. 1991;4:610-614.
11. Bursztyn M, Ben-Ishay D, Melder J, Raz I. Chronic exogenous hyperinsulinemia accelerates the development of hypertension in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1995;1(suppl):S28-S29.
12. Zimlichman R, Matas Z, Gass S, Shahar C, Barg J, Nakash I, Zeided L, Eliahou H. Hyperinsulinemia increases blood pressure in genetically predisposed spontaneously hypertensive rats but not in normotensive Wistar-Kyoto rats. J Hypertens. 1995;13:1009-1013.
13. Reaven GM, Ho H, Hoffman BB. Effects of a fructose-enriched diet on plasma insulin and triglyceride concentration in SHR and WKY rats. Horm Metab Res. 1990;22:363-365.
14. Tomiyama H, Kushiro T, Abeta H, Kurumatani H, Taguchi H, Kuga N, Saito F, Kobayashi F, Otsuka Y, Kanmatsuse K, Kajwara N. Blood pressure response to hyperinsulinemia in salt-sensitive and salt-resistant rats. Hypertension. 1992;20:596-600.
15. Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am J Physiol. 1991;260:R764-R768.
16. Hsieh PS, Huang WC. Chemical sympathectomy attenuates hyperinsulinemia-induced hypertension in conscious rats. Nutr Metab Cardiovasc Dis. 1993;3:173-178.
17. Meehan WP, Buchanan TA, Hsueh W. Chronic insulin administration elevates blood pressure in rats. Hypertension. 1994;23(pt 2):1012-1017.
18. Defronzo RA. The effects of insulin on renal sodium metabolism. Diabetalogia. 1981;21:165-171.
19. Young JB. Effect of experimental hyperinsulinemia on sympathetic nervous system activity in rats. Life Sci. 1988;43:193-200.
20. Iyer SN, Katovich MJ. Vascular reactivity to phenylephrine and angiotensin II in hypertensive rats associated with insulin resistance. Clin Exp Hypertens. 1996;18:227-242.
21. Brands MW, Harrison DL, Keen HL, Gardner A, Shek EW, Hall JE. Insulin-induced hypertension in rats depends on an intact renin-angiotensin system. Hypertension. 1997;29:1014-1019.
22. Waeber B, Brunner HR. The renin-angiotensin system: role in experimental and human hypertension. In: Zanchett A, Mancia G, eds. Handbook of Hypertension: Pathophysiology of Hypertension. Amsterdam, Netherlands: Elsevier Science BV: 1997;17:847-852.
23. Santoro D, Natali A, Palombo C, Brandi LS, Piatti M, Chione S. Effects of chronic angiotensin converting enzyme inhibitor on glucose tolerance and insulin sensitivity in essential hypertension. Hypertension. 1992;20: 181-191.
24. Iimura O, Shimamoto K, Matsuda K, Masuda A, Takizawa H, Higashiura K, Miyazaki Y, Hirata A, Ura N, Nakagawa M. Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensive. Am J Hypertens. 1995;8:353-357.
25. Iyer SN, Katovich MJ. Effects of chronic losartan potassium treatment on fructose-induced hypertension. Life Sci. 1994;55:139-144.
26. Shimamoto K, Ura N, Nakagawa M, Higashium K, Takizawa H, Miyazaki Y, Nomura N, Hirata A, Takagawa Y, Murakami H, Limura O. The mechanisms of the improvement of insulin sensitivity by angiotensin converting enzyme inhibitor. Clin Exp Hypertens. 1996;18:257-266.
27. Navarro-Cid J, Maeso R, Perez-Vizcaino F, Cachofeiro V, Ruilope LM, Tamargo J, Lahera V. Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat. Hypertension. 1995;26(pt 2):1074-1078.
28. Bunag RD, Krizan-Agbas D, Itoh H. Sympathetic activation by chronic insulin treatment in conscious rats. J Pharmacol Exp Ther. 1991;259: 131-138.
29. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev: 1985;6:45-86.
30. Hall JE, Brands MW, Zappe DH, Alonso-Galicia M. Cardiovascular actions of insulin: are they important in long-term blood pressure regulation? Clin Exp Pharmacol Physiol. 1995;22:689-700.
31. Brands MW, Hildebrandt DA, Mizelle L, Hall JE. Hypertension during chronic hyperinsulinemia in rats is not salt-sensitive. Hypertension. 1992; 19(suppl I):I-83-I-89.
32. Kost CK, Jackson EK. Enhanced renal angiotensin II subtype 1 receptor responses in the spontaneously hypertensive rat. Hypertension. 1993;21: 420-431.
33. Guan S, Fax J, Mitchell KD, Navar LG. Angiotensin and angiotensin converting enzyme tissue levels in two-kidney, one clip hypertensive rats. Hypertension. 1992;20:763-767.
34. Collister JP, Hornfedldt BJ, Osbom JW. Hypotensive response to losartan in normal rats: role of Ang II and the area postrema. Hypertension. 1996;27(pt 2):598-606.
35. Keen HL, Brands MW, Smith MJ Jr, Hall JE. Maintenance of baseline angiotensin II potentiates insulin hypertension in rats. Hypertension. 1998;31:637-642.
36. Wong PC, Price WA Jr, Chiu AT, Carini DJ, Duncia JV, Johnson AL, Wexler RR, Timmermans PBMWM. Nonpeptide angiotensin II receptor antagonists: studies with EXP 9270 and Dup 753. Hypertension. 1990; 15:823-834.
37. Burnier M, Centeno G, Grouzman E, Walker P, Wacber B, Brunner HR. In vitro effect of Dup 753, a nonpeptide angiotensin II receptor antagonist, on human platelet and rat vascular smooth muscle cells. Am J Hypertens. 1991;4:438-443.
38. Munzenmaier DH, Greene AS. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension. 1996;27(pt 2):760-765.
39. Viswanathan M, Tsutumi K, Correa FMA, Saavedra JM. Change in the expression of angiotensin receptors subtypes in the rat aorta during development. Biochem Biophys Res Commun. 1991;179:1361-1367.
40. 2 receptor ligands CGP 42112 B and PD 123319 in the sodium-depleted rat. Eur J Pharmacol. 1993;249:85-93.
41. Dudley DT, Panek RL, Major TC, Lu GH, Bruns RF, Klinkefus BA, Hodges JC, Weishaar RE. Subclasses of angiotensin II binding sites and their function significance. Mol Pharmacol. 1990;38:370-377.
42. Keen HL, Brands MW, Alonso-Galica M, Hall JE. Chronic adrenergic receptor blockade does not prevent hyperinsulinemia-induced hypertension in rats. Am J Hypertens. 1996;9:1192-1199.
43. Shamiss A, Carrol J, Rosenthal T. Insulin resistance in secondary hypertension. Am J Hypertens. 1992;5:26-28.
44. Buchanan TA, Sipos GF, Yip K-P. Glucose tolerance and insulin action in rats with renovascular hypertension. Hypertension. 1991;18:341-347.
45. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med. 1994;331:1188-1193.
46. Landin K, Tengborn L, Smith U. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J Intern Med. 1991;229:181-187.